Lappaconitine myl)-lysine LY117018 did not block E2-induced

LY117018 did not block E2-induced pRb phosphorylation

Smiles: CC(C)C(NC(=O)C1C=CC2=CC=CC=C2N=1)C(=O)NC(CC(O)=O)C(=O)COC1=C(F)C=CC=C1F

Lawrence J

ClH/c1-31-22-8-5-20(6-9-22)28-27(25-14-7-21(30)19-26(25)34-28)33-24-12-10-23(11-13-24)32-18-17-29-15-3-2-4-16-29

Lappaconitine myl)-lysine LY117018 did not block E2-inducedLappaconitine, isolated from Aconitum sinomontanum Nakai, was characterized as analgesic principle. IC50 value: Target: In vitro: In vivo: Lappaconitine was characterized as analgesic principle by our laboratory. The results suggest that lappaconitine can produce analgesia, possibly through a decrease in cellular calcium availability and PAG may be involved in the Ca2+ antagonistic effect on lappaconitine analgesia . Changes in lappaconitine levels in